In its latest report on Myocardial Infarction Treatment Market provides a concise analysis of the recent market trends. The report further includes statistics, market forecasts and revenue estimations, which in addition highlights its status in the competitive domain as well as expansion trends adopted by major industry players.
Myocardial Infarction Treatment Market Size
Myocardial Infarction Treatment Market is valued at USD 1524.5 Million in 2020 and expected to reach USD 2353.5 Million by 2027 with the CAGR of 6.4% over the forecast period.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.com/requestSample/PostId/1599
Scope of Myocardial Infarction Treatment Market Report:
Myocardial Infarction is generally known as a heart attack. It is an irreversible acute medical situation, which precedes the necrosis of heart muscles secondary to prolonged ischemia. This happens when blood flow reduces or stops to a part of the heart, affecting damage to the heart muscle. It is caused by the blockage in the supply of oxygen-rich blood to heart muscles, causing lasting heart muscle injury as well as the death of cells. The blockage is because of atherosclerosis, a procedure in which the plaque (fatty patches) is developed on the inner sidewall of the coronary artery or one of its lesser branches. If the plaque is cracked or ruptured, the blood clot is created inside the artery preventing the blood flow. In most of the cases, myocardial infarctions are situated in the posterior, septal, anterior, lateral, or inferior walls of the left ventricle of the heart. Thus, lack of oxygen triggers distinct pain in the chest and death of myocardial tissue, which indicates myocardial infarction in humans.
Myocardial Infarction are of three types which are ST-segment elevation myocardial infarction (STEMI), non-ST segment elevation myocardial infarction (NSTEMI), and Silent heart attack. Such diseases can be diagnosed by chest x-ray, CT scan, electrocardiography, echocardiography, blood test, and other diagnostic test. Moreover, the heart attack can be cured by numerous medications including antiplatelet agents, aspirin thrombolytic, and other medicines and some surgical processes comprising angioplasty bypass surgery, heart transplant, and so on. Certain devices used for the treatment of myocardial infarction are pacemakers, left ventricular assist devices, and implantable cardioverter-defibrillator. In 1879, the pathologist Ludvig Hektoen determined that myocardial infarction was produced by coronary thrombosis secondary to sclerotic alterations in the coronaries.
Contrary to the projected surge in myocardial infarction (MI) associated with the novel coronavirus, there have been reports that the COVID‐19 pandemic has knowingly reduced the number of activations for ST‐elevation myocardial infarction (STEMI) in most cities with devastating spread of COVID‐19 cases. And a survey showed that the COVID-19 pandemic significantly affected the heart-healthy lifestyle and anxiety levels of patients with a history of premature MI who were already in regular follow-up in a tertiary out-patient prevention clinic before the pandemic. Thus, the pandemic has enhanced the sale of drugs and eventually the growth of the myocardial infarction treatment market in the forecast period.
The regions covered in Myocardial Infarction treatment market report are North America, Europe, Asia-Pacific, and Rest of the World. Based on country level, the market of myocardial infarction treatment is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, Southeast Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Myocardial Infarction Treatment Companies
Global myocardial infarction treatment market reports cover prominent players like
- Nortech Systems, Inc.
- Tecomet, Inc.
- Celestica Inc.
- Heraeus Holding
- Flextronics International Ltd.
- Integer Holdings Corporation
- Plexus Corp.
- West Pharmaceutical Services, Inc.
- Sanmina Corporation
Request for Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/1599
Myocardial Infarction Treatment News
FDA-Approved Treatment Significantly Reduces Infarct Size in MI Patients
April 4th, 2019; TherOx received premarket approval from the Food and Drug Administration (FDA) for SuperSaturated Oxygen (SSO2) Therapy for use in patients who suffer left anterior descending (LAD) ST-elevation myocardial infarction (MI). The approval was based on data from several clinical trials. In a pivotal randomized controlled trial, a post-PCI infusion of SSO2 resulted in a significant reduction in infarct size (primary endpoint) compared with PCI alone. With regard to safety, the incidence of major adverse cardiovascular events (MACE) measured at 30 days was similar in both arms, indicating noninferiority between the 2 groups.
Myocardial Infarction Treatment Market Dynamics
Rising incidences of cardiovascular diseases (CVDs), increasing incidences of coronary artery disease and changes in lifestyle are some of the major factors driving the growth of myocardial infarction treatment market. Cardiovascular diseases are conditions that affect the function of the heart such as Heart failure, congenital heart disease, Pericardial disease, Heart attack, and many hearts related diseases.
Cardiovascular diseases are increased all over the world owing to high blood pressure, smoking, diabetes, and so on. For example; according to the Centers for Disease Control and Prevention (CDC), approximately 655,000 people in the U.S. die of heart disease annually. One person dies every 36 seconds in the United States from cardiovascular disease. Also, according to the Eurostat 2020, Also, around 3.9 million people die of cardiovascular disease in Europe every year, and cardiovascular disease accounts for almost 45% of all deaths in Europe.
In addition, growing number of smokers, increasing cases of obesity, diabetes, hypertension and others are also fostering the market growth. For example, according to the World Health Organization 2020, smoking kills more than 8 million people each year. Secondhand smoking triggers more than 1.2 million premature deaths per year and results in severe cardiovascular diseases. The smoking increases the risk of heart diseases. Therefore, rise in number of smokers is also supplementing the growth of global myocardial infarction treatment Market. However, rise in overall healthcare expenditure and high rates of clinical trials are some of the market-limiting factors may hamper the growth of myocardial infarction market in the forecast period. In spite of that, surge in acceptance of newer treatment technologies by developing nations and technology advances are likely to create new avenues for myocardial infarction market in the coming future.
Key Benefits of Global Myocardial Infarction Treatment Market Report
- Global Myocardial Infarction Treatment Market report covers in depth historical and forecast analysis.
- Global Myocardial Infarction Treatment Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global Myocardial Infarction Treatment Market report helps to identify opportunities in marketplace.
- Global Myocardial Infarction Treatment Market report covers extensive analysis of emerging trends and competitive landscape.
Complete Report Details @ https://brandessenceresearch.com/healthcare/myocardial-infarction-treatment-market
Global Myocardial Infarction Treatment Market Segmentation:
The global myocardial infarction treatment market is segmented on the basis on product type, distribution channel, and region & country level. Based on product type, the myocardial infarction market is classified as Antiplatelet agents, Glycoprotein IIb/IIIa inhibitors, antithrombotic agents, beta-adrenergic blockers, vasodilators, angiotensin-converting enzyme (ACE) inhibitors, angiotensin-receptor blockers, analgesics, and thrombolytics. Based on distribution channel, the market is categorized as hospitals, hospitals pharmacies, drug stores, and online drug stores.
By Product Type:
- Antiplatelet agents
- Glycoprotein IIb/IIIa inhibitors
- Antithrombotic agents
- Beta-adrenergic blockers
- Angiotensin-Converting Enzyme (ACE) inhibitors
- Angiotensin-Receptor blockers
By Distribution Channel:
- Hospital Pharmacies
- Drug Stores
- Online Drug Stores
By Regional & Country Analysis: (North America, U.S., Canada, Europe, U.K., France, Germany, Italy,Asia Pacific, China, Japan, India, Southeast Asia, Latin America, Brazil, Mexico, Middle East and Africa, GCC, Africa, Rest of Middle East and Africa)
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global Myocardial Infarction Treatment Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Myocardial Infarction Treatment Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Myocardial Infarction Treatment Market: Trends
2.8. Porter’s Five Forces Analysis
2.9. Market Attractiveness Analysis
3. Chapter – Global Myocardial Infarction Treatment Market Overview: Quantitative Analysis
4. Chapter – Global Myocardial Infarction Treatment Market Analysis: Segmentation By Type
5. Chapter – Global Myocardial Infarction Treatment Market Analysis: Segmentation By Application
About Us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org
Other Related Report:
Vaccines Vials Market Size: The global vaccines vials market in terms of revenue was worth of USD 459.6 Million in 2020 and is expected to reach USD 901.3 Million in 2027, growing at a CAGR of 10.1% from 2021 to 2027
(WTE) Waste to Energy Market Size: Global demand for (WTE) Waste to Energy Market Size, in terms of revenue, was worth of USD 32.15 Billion in 2017 and is expected to reach USD 49.44 Billion in 2027, growing at a CAGR of 4.4% from 2021 to 2027.